156 related articles for article (PubMed ID: 33980944)
21. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
Tsutani Y; Mimura T; Kai Y; Ito M; Misumi K; Miyata Y; Okada M
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1089-1096.e1. PubMed ID: 28483268
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer.
Hamada S; Ichiyasu H; Ikeda T; Inaba M; Kashiwabara K; Sadamatsu T; Sato N; Akaike K; Okabayashi H; Saruwatari K; Tomita Y; Saeki S; Hirata N; Yoshinaga T; Fujii K
BMC Pulm Med; 2019 Apr; 19(1):72. PubMed ID: 30940113
[TBL] [Abstract][Full Text] [Related]
23. Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors.
Voltolini L; Bongiolatti S; Luzzi L; Bargagli E; Fossi A; Ghiribelli C; Rottoli P; Gotti G
Eur J Cardiothorac Surg; 2013 Jan; 43(1):e17-23. PubMed ID: 23129356
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
Ishikawa G; Acquah SO; Salvatore M; Padilla ML
Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
[TBL] [Abstract][Full Text] [Related]
25. Effect of collagen vascular disease-associated interstitial lung disease on the outcomes of lung cancer surgery.
Maeda H; Kanzaki M; Sakamoto K; Isaka T; Oyama K; Murasugi M; Onuki T
Surg Today; 2017 Sep; 47(9):1072-1079. PubMed ID: 28247107
[TBL] [Abstract][Full Text] [Related]
26. Serum heme oxygenase-1 measurement is useful for evaluating disease activity and outcomes in patients with acute respiratory distress syndrome and acute exacerbation of interstitial lung disease.
Nagasawa R; Hara Y; Murohashi K; Aoki A; Kobayashi N; Takagi S; Hashimoto S; Kawana A; Kaneko T
BMC Pulm Med; 2020 Nov; 20(1):310. PubMed ID: 33238962
[TBL] [Abstract][Full Text] [Related]
27. Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease.
Hagiwara Y; Nakayama Y; Kudo S; Hayakawa T; Nakamura N; Kitamoto Y; Takahashi S; Tsujino K; Kubo N; Tamaki Y; Nagata Y;
J Radiat Res; 2020 Jul; 61(4):563-574. PubMed ID: 32363376
[TBL] [Abstract][Full Text] [Related]
28. The utility of ground-glass attenuation score for anticancer treatment-related acute exacerbation of interstitial lung disease among lung cancer patients with interstitial lung disease.
Nishiyama N; Honda T; Sema M; Kawahara T; Jin Y; Natsume I; Chiaki T; Yamashita T; Tsukada Y; Taki R; Miyashita Y; Saito K; Tateishi T; Sakashita H; Miyazaki Y
Int J Clin Oncol; 2020 Feb; 25(2):282-291. PubMed ID: 31720993
[TBL] [Abstract][Full Text] [Related]
29. Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosis.
Zheng JN; Li Y; Yan YM; Yu Y; Shao WQ; Wang Q
Arthritis Res Ther; 2020 May; 22(1):110. PubMed ID: 32393322
[TBL] [Abstract][Full Text] [Related]
30. Preoperative CT Findings for Predicting Acute Exacerbation of Interstitial Pneumonia After Lung Cancer Surgery: A Multicenter Case-Control Study.
Ozawa Y; Shibamoto Y; Hiroshima M; Nakagawa M; Ono A; Hanaoka R; Yamamoto A; Tominaga J; Kawada H; Koyama M; Takumi K; Tsubakimoto M; Egashira R; Tsushima F; Kikuchi Y; Izumi Y; Ushio T; Kimura M; Ichikawa S; Kitamura N; Matsushita S; Okauchi K; O'uchi T; Ishikawa H; Kitase M
AJR Am J Roentgenol; 2021 Oct; 217(4):859-869. PubMed ID: 33852356
[No Abstract] [Full Text] [Related]
31. Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1.
Kakiuchi S; Hanibuchi M; Tezuka T; Saijo A; Otsuka K; Sakaguchi S; Toyoda Y; Goto H; Kawano H; Azuma M; Ogushi F; Nishioka Y
Respir Investig; 2017 Mar; 55(2):145-152. PubMed ID: 28274530
[TBL] [Abstract][Full Text] [Related]
32. Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy.
Sekine A; Matama G; Hagiwara E; Tabata E; Ikeda S; Oda T; Okuda R; Kitamura H; Baba T; Satoh H; Misumi T; Komatsu S; Iwasawa T; Ogura T
Thorac Cancer; 2022 Sep; 13(17):2443-2449. PubMed ID: 35840339
[TBL] [Abstract][Full Text] [Related]
33. Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation.
Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Fujitaka K; Hamada H; Hattori N
Respir Investig; 2022 Jul; 60(4):531-542. PubMed ID: 35504814
[TBL] [Abstract][Full Text] [Related]
34. What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?
Miyajima M; Watanabe A; Sato T; Teramukai S; Ebina M; Kishi K; Sugiyama Y; Kondo H; Kobayashi S; Takahashi Y; Ito H; Yamamoto R; Sawada S; Fujimori H; Okabe K; Arikura J; Shintani Y; Nakamura H; Toyooka S; Hasumi T; Watanabe T; Hata Y; Iwata H; Aoki M; Funai K; Inoue S; Kawashima O; Iida T; Date H
Surg Today; 2018 Apr; 48(4):404-415. PubMed ID: 29124429
[TBL] [Abstract][Full Text] [Related]
35. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: clinical features and prognosis.
Izuka S; Yamashita H; Iba A; Takahashi Y; Kaneko H
Rheumatology (Oxford); 2021 May; 60(5):2348-2354. PubMed ID: 33241299
[TBL] [Abstract][Full Text] [Related]
36. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
[TBL] [Abstract][Full Text] [Related]
37. Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases.
Kimura T; Nojiri T; Hosoda H; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
Eur J Cardiothorac Surg; 2015 Oct; 48(4):e85-91. PubMed ID: 26224340
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
[TBL] [Abstract][Full Text] [Related]
39. The ATS/ERS/JRS/ALAT statement "IPF by HRCT" could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer.
Asai N; Katsuda E; Hamanaka R; Kosaka K; Matsubara A; Nishimura M; Tanaka H; Yokoe N; Takahashi A; Yamaguchi E; Kubo A
Tumori; 2017 Jan; 103(1):60-65. PubMed ID: 27791236
[TBL] [Abstract][Full Text] [Related]
40. Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer.
Shintani Y; Ohta M; Iwasaki T; Ikeda N; Tomita E; Kawahara K; Ohno Y
Gen Thorac Cardiovasc Surg; 2010 Apr; 58(4):182-5. PubMed ID: 20401711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
